Will Trump’s Prescription Drug Deals Really Lower Prices?

Facing unprecedented pressure from the Trump administration, some of the world’s top drugmakers promise to cut prices. But experts say the savings might not be what they seem.

Guests:

• Michael Cannon, Director of Health Policy Studies, Cato Institute
• Stacie Dusetzina, Professor of Health Policy, Vanderbilt University
• Darius Lakdawalla, Chief Scientific Officer, USC Schaeffer Center
• Pete Loftus, Reporter, Wall Street Journal
• Ben Rome, Assistant Professor of Medicine, Harvard Medical School
• Leslie Walker, Senior Reporter, Tradeoffs

We want to hear from you! Our audience survey takes less than ten minutes, and you’ll be entered to win one of two $50 Bookshop.org gift cards.

Learn more and read a full transcript on our website.

Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.

Support this type of journalism today, with a gift.

Hosted on Acast. See acast.com/privacy for more information.